Entries by Harshita Sharma

Evercode™ Whole Transcriptome v4

Introducing Evercode™ Whole Transcriptome v4

Evercode™ Whole Transcriptome v4 from Parse Biosciences delivers higher sensitivity single cell transcriptomics with a streamlined, instrument-free workflow built for labs ready to scale.

Detect More Biology from Every Cell — Without Adding Instruments to Your Bench

Single cell RNA sequencing has transformed how we interrogate complex tissues, immune repertoires, and disease biology — but for many labs, the barriers to entry and scale remain real. Instrument dependencies and low cell recovery have limited what’s practically achievable. Evercode™ Whole Transcriptome v4 addresses these constraints directly. Built on Parse Biosciences’ proven combinatorial barcoding chemistry, v4 enhances transcript and gene detection efficiency across sequencing depths, giving you sharper resolution of rare cell populations and lowly expressed genes without requiring specialised hardware.

What makes v4 a meaningful step forward is the combination of improved sensitivity with a redesigned, bead-based workflow. Centrifugation steps have been replaced with magnetic bead clean-up, resulting in up to 75% higher cell retention — a significant gain when working with limited or precious samples. Fewer pipetting steps, greater automation compatibility, and increased confidence at critical handling stages mean your experiments scale more reliably, whether you’re processing a handful of samples or running large cohort studies across conditions and replicates.

A History of Innovation.
Now Even Greater Sensitivity.

Higher Sensitivity, Greater Biological Resolution

Improves transcript detection efficiency at every sequencing depth. Clearer identification of rare cell states and detection of genes.

Instrument-Free Scalability

No capital equipment purchase.
No booking time on a shared instrument.
Single cell experiments start with a standard cell or nuclei suspension and a set of reagent plates — nothing more.

Bead-Based Workflow for Higher Cell Recovery

Retaining up to 75% more cells through critical clean-up steps.

Built for Automation and Reproducibility

Highly compatible with liquid handling systems, supporting consistent results across operators and sites.

Watch What the Leaders Have To Say

They talk about the problem they are trying to solve for a researcher, how has the feedback received from customers influenced the evolution of Evercode and more....

Ebru Boslem, PhD

ANZ Market Manager - Research Genomics

Our specialist team can advise on experimental design, sample preparation, and sequencing strategy — reach out to me directly and we can discuss your needs.

Why It Matters to You

1. For Immunology & Oncology Researchers

Pair whole transcriptome profiling with Evercode TCR or BCR kits to connect clonotype identity with transcriptional phenotype at single cell resolution.

2. For Oncology & Tumour Biology Labs

Higher gene detection per cell means better characterisation of malignant subpopulations, stromal interactions, and therapy-resistant states — even in samples with limited cell numbers from biopsies or PDX models.

3. For Cardiomyocyte and Complex Tissues Studies

Perfect for large cell types which may clog the microfluidic single cell instruments. Parse combinatorial barcoding occurs in plates inside fixed cell eliminating the need for cell suspension flow that can damage & stress cells.

4. For Core Facilities & Service Labs

v4's automation-ready workflow and consistent performance across operators reduce turnaround times and support diverse project demands without tying up instrument slots.

Explore Competitive Comparisons

Comparison 1: Evercode™ WT v4 vs. Chromium™ GEM-X Single Cell 3' v4 — Human PBMCs

When tested head-to-head using frozen PBMCs from two donors processed in independent labs, Evercode WT v4 demonstrated a clear increase in transcript detection compared to the Chromium GEM-X 3′ platform. Cell type proportions were equivalently represented across both technologies, confirming that Evercode’s combinatorial barcoding approach captures the same biological diversity — with the added advantage of lower ambient RNA contamination and a significant reduction in mitochondrial and ribosomal read content. For labs looking to maximise usable data per read, that’s sequencing budget going directly toward biology rather than noise.

Download Tech Note
Instantly!


    Comparison of Evercode™ WT v4 and Chromium™ GEM-X Single Cell 3’ Kit v4 in Human PBMCs

    Gene Detection. Median genes detected per cell across different sequencing depths for PBMC donor 1 (top) and PBMC donor 2 (bottom). Aliquots derived from the same donor cryovial lot were distributed to separate laboratories for processing with either Evercode WT v4 or Chromium GEM-X 3’ v4 workflows and analyzed using their respective data analysis pipelines.

    Comparison 2: Evercode™ WT v4 vs. Chromium™ Flex v2 (Apex) — Fixed Human PBMCs

    In a parallel comparison using fixed PBMCs, Evercode WT v4 retained over four times the number of cells through processing and detected more than 60% higher median transcripts per cell — including diverse RNA biotypes that probe-based approaches can miss entirely. Because Evercode uses an RT-based method rather than predefined probe panels, you’re not limited to a curated gene list; you capture the full transcriptional landscape of each cell. For researchers working with fixed clinical samples or multi-site collections, this means more cells, more genes, and more confidence in what the data is telling you.

    Download Tech Note
    Instantly!


      Detected Transcripts and RNA Biotypes Comparison. Total transcripts detected in human PBMCs across sequencing depths, including protein-coding genes and other RNA biotypes. Other biotypes comprise lncRNA, miRNA, snRNA, snoRNA, miscRNA, pseudogenes, and Ig/TCR genes.

      Cell Retention & Assay Time. Overall retention rates were calculated by multiplying stepwise retention across all samples, and total assay times were based on vendor recommendations for four PBMC aliquots.

      Related Products

      Evercode™ Whole Transcriptome Range

      Evercode WT Mini — Ideal for pilot studies and labs getting started with single cell. Profile up to 10,000 cells per sample.

      Evercode WT — The standard configuration for most single cell transcriptomics experiments.

      Evercode WT Mega — Designed for larger experiments requiring higher cell throughput per run.

      Evercode WT Penta — Maximum scale for ambitious, multi-sample study designs.

      Immune Profiling

      Evercode TCR — Paired T cell receptor sequencing with whole transcriptome at single cell resolution.

      Evercode BCR — Paired B cell receptor sequencing with whole transcriptome at single cell resolution.

      Additional Capabilities

      Evercode Fixation — Fix samples at the point of collection and process later — ideal for clinical workflows and multi-site studies.

      Gene Select — Targeted gene panels to reduce sequencing costs while retaining biological insight.

      CRISPR Detect — Single cell readouts for pooled CRISPR screening experiments.

      Do you have a question?

      Our team is one form away.

      We only need below information to serve you better. Decode Science respects your privacy and will never spam you with unrelated content.




        BioinformaticsCloningCRISPREpigeneticsGenomicsLong ReadMetagenomicsMicrobiomeNeurologyProteinRNASingle CellSpatialSmall RNASynthetic BiologyOther

        You agree to receive communications from Decode Science. View our Privacy Policy

        NZ Morning & Afternoon Tea in March 2026

        NZ Morning & Afternoon Tea in March 2026

        Five cities. One week. BYO coffee and come grab a snack, talk genomics, and meet the team.

        Dates: 23–27 March 2026

        We’re bringing the Decode Science team to your doorstep, with morning and afternoon teas where you can chat with us about whatever’s on your bench or in your pipeline.

        Whether you’re working with CRISPR workflows, gene synthesis, spatial transcriptomics, single-cell, or variant interpretation — or something we haven’t even thought of yet — we’d love to hear about it.

        Daina, Jessie, and Chris will be covering ground from Dunedin to Auckland, stopping at universities and research institutes along the way. Come say hello, ask questions, share what you’re working on, or just grab a good coffee on us.

        Synthego logo

        CRISPR & gene editing (Synthego / Editco)

        Gene synthesis & cloning workflows (Twist Bioscience)

        STOmics White Background Logo

        Spatial transcriptomics / Single Cell (STOmics / Parse Biosciences)

        Biomarker Detection (Quanterix / Akoya)

        MGI

        Sequencing platforms (MGI)

        Functional cell analysis (Bruker Cellular Analysis)

        Bioptic

        Variant interpretation & clinical genomics

        …or anything else on your mind

        CLICK THE DATE BELOW TO REGISTER

        Monday 23 March — Christchurch

        On Site: Daina & Jessie

        Morning tea : University of Canterbury

        Tuesday 24 March — Nelson

        On Site: Daina & Jessie

        Afternoon tea : Plant and Food Research – Nelson

        Wednesday 25 March — Dunedin

        On Site: Daina, Jessie & Chris

        Morning tea : University of Otago — South Campus (Pathology)

        Afternoon tea : University of Otago — North Campus (Biochemistry)

        Thursday 26 March — Wellington

        On Site: Daina, Jessie & Chris

        Afternoon tea : Victoria University of Wellington

        Friday 27 March — Auckland

        On Site: Daina, Jessie & Chris

        Morning tea : University of Auckland — SBS (School of Biological Sciences) – Tea Room

        MGISTP-B1000

        MGI STP-B1000

        The STP-B1000 is designed for laboratories that require accurate, repeatable separation and transfer of blood components without compromising traceability or efficiency. It precisely recognizes plasma, buffy coat, and red blood cells within centrifuged blood collection tubes and transfers each component with high positional accuracy, reducing manual handling and the risk of cross-contamination. Integrated barcode tracking ensures every transfer remains fully traceable, preventing sample mismatches and data integrity issues in high-throughput workflows.

        Operation is intentionally streamlined… users define only the component type, transfer volume, and number of transfers before initiating the process with a single click. This simplicity minimizes training requirements while delivering consistent, standardized blood processing suitable for clinical, biobanking, and research applications.

        Accurately Identify Blood Components & efficiently recover the buffy coat

        Precise Layer Positioning

        Dual light photography, high-definition camera, built-in self developed image processing

        Efficient Buffy Coat Recovery

        Spiral aspirate, 3-axis linkage control & recovery rate of 95% or more

        Dual Detection Technology

        Pressure based liquid level detection (pLLD) & capacitive liquid level detection (cLLD)

        Chris Wicky

        Clinical Genomics Manager - ANZ & Country Manager - NZ

        As the official distributor of MGI in Australia and New Zealand, Decode Science is providing local access to STP-B1000 solutions with region-based technical and application support. Simply talk to me and we can discuss your research needs.

        Product Components & Software Functions

        Integrated Scanning, Identification, Transferring

        Download Brochure Instantly!


          Product Specifications

          Indicators Parameter
          Pipettor Pipette Range
          1 μL–1000 μL
          Pipette Accuracy
          1 μL: CV≤8%, accuracy: ±10%
          50 μL: CV≤1%, accuracy: ±2%
          200 μL: CV≤1%, accuracy: ±2%
          1000 μL: CV≤1%, accuracy: ±1%
          Independent 8-channel Pipettor
          Detection Mode pLLD, cLLD
          Throughput 1–192 samples/run
          Size 1420 mm (L) × 1010 mm (W) (without door handle) × 1120 mm (H)
          Weight ~250 kg

          MGI Portfolio

          Contact Decode Science Today

          We only need these information to serve you better. Decode Science respects your privacy and will never spam you with unrelated content.




            BioinformaticsCloningCRISPREpigeneticsGenomicsLong ReadMetagenomicsMicrobiomeNeurologyProteinRNASingle CellSpatialSmall RNASynthetic BiologyOther

            You agree to receive communications from Decode Science. View our Privacy Policy

            Parse Single Cell Grant – Apply Now

            Single Cell Grant - Apply Now

            Submission Deadline Passed:
            February 20 - 11:59 PM AEST

            Understanding single-cell biology at the whole-transcriptome level is critical for mechanistic insight in cancer and complex biology. Generating robust proof-of-concept data ahead of a grant cycle or biotech pitch can be the difference between progress and delay.

            Decode Science, in partnership with Parse Biosciences, is offering a Parse Single-Cell Grant to support researchers across Australia and New Zealand.

            What the Grant Supports

            Successful applicants will receive support to assay up to 100,000 single cells across 12 samples, including sequencing.

            Parse Biosciences’ Evercode™ technology enables scalable single‑cell RNA sequencing with high transcript capture—without specialised hardware—making it suitable for both new and established single‑cell labs.

            What's Included

            1. Parse Evercode™ WT single‑cell kit (up to 100,000 cells) & one cell or nuclei fixation kit for up to 12 samples

            2. Sequencing included

              1. 20,000 reads per cell

              2. Sequencing costs covered by Decode Science and SAGC

            3. Application and experimental feasibility review by Parse Application Support

            Application Requirements

            Applicants must submit an abstract (maximum 300 words) outlining:

            1. Experimental objectives

            2. Sample type and number

            3. Expected cell count per sample

            4. Plans for scale‑up and projected throughput

            Key Dates

            1. Abstract submission deadline: 20 February 2026

            2. Internal application review: 20 February – 6 March 2026

            3. Winner + 5 consolation prizes announced: 9 March 2026

            4. Orders to be placed by: 25 March 2026

            5. Kit delivery completed by: 10 June 2026

            Ebru Boslem

            ANZ Market Manager

            If you have questions or would like guidance on suitability or the application process, please reach out to me directly.

            Parse Single Cell Grant Application – Information Session

            Single Cell Grant Application - Information Session

            Join this webinar to learn about the Parse Biosciences Single-Cell Grant and how researchers can access Evercode™ single-cell technology.

            This session is designed for researchers who are new to Parse Biosciences and are interested in applying for the grant.

            What we’ll cover:

            1. Overview of modern single-cell sequencing approaches

            2. Details of the Parse Biosciences grant program

            3. Eligibility and evaluation criteria

            4. What makes a strong grant application

            Attendance is strongly recommended for anyone planning to apply, as the session will include important guidance and updates related to the application process. A recording will be available for registered participants.

            Registration is free.

            BiOptic Customisable Fragment Analysis

            Cost-Effective Customisable Fragment Analysis.


            Customisable Qsep solutions for genomics labs — up to 4x more cost-effective with faster turnaround times than traditional systems.

            Bioptic

            Scott Coutts

            Clinical Field Application Scientist

            Jiyoti Verma

            Field Application Scientist

            Fragment analysis shouldn’t slow your research down.

            Many genomics labs and core facilities struggle with:


            How about custom-configured Qsep bio-fragment analysers?

            Decode Science provides custom-configured Qsep bio-fragment analysers designed for academic labs and core facilities that need:

            A system configured to your workflow

            Support to optimise how you run it

            Lower operating costs without sacrificing performance

            Backed by:

            How It Works

            1

            Insert the gel cartridge

            2

            Load Sample & Buffer

            3

            Run Q- Analyser

            Results in 2–7 minutes

            Easy to operate: 3 mins to set up and start

            No need for gel and sample preparation

            High sensitivity: 5 pg/μl can be detected

            High resolution: 1 to 4 bp resolution

            Reliable sizing & quantitative result

            Built for modern genomics workflows

            NR1 Cartridge BiOptic

            NGS library QC

            NR1 Cartridge BiOptic

            Genomic & plasmid DNA

            NR1 Cartridge BiOptic

            Multiplex PCR

            NR1 Cartridge BiOptic

            CRISPR workflows

            NR1 Cartridge BiOptic

            Low concentration RNA (ctDNA / cfDNA)

            NR1 Cartridge BiOptic

            SNP, RFLP, MDx

            NR1 Cartridge BiOptic

            Protein profiling & antibody purity

            NR1 Cartridge BiOptic

            Total RNA QC & fragment analysis

            Proof it works — Fast, Sensitive, Reliable (performance of Qsep platforms)

            1. Reproducibility: run the same marker x 50

            2. Stability: same sample run at 3 different time points

            3. Resolution: 1~4bp can be resolved below 500bp

            4. High Sensitivity: Standard cartridge can detect down to 2 pg/ul, the sensitivity of the high sensitivity cartridge can be up to 10 times higher than the standard cartridge

            cfDNA / ctDNA High-Demand Application

            cfDNA Quality Control

            Trusted by Genomics Labs
            and Core Facilities

            How Can Decode Science Help You?

            1

            Submit Your Custom Request

            This will be looked at by our team

            2

            Decode Team Schedules Meeting

            This meeting will be the first session to understand your requirements ever further

            3

            Guide with the solution

            Decode Science team will prepare a guide and help with your installation/set up

            4

            Ongoing Support Provided

            For future support, simply reach out to the Decode representative.

            we’re here to all your questions


            Qsep platforms combine high sensitivity, fast turnaround (2–7 mins per run), and flexible configurations (1 – 100+ samples) — all at a significantly lower cost than traditional systems. You get performance without paying for features you don’t need.

            Qsep supports DNA, RNA, and protein applications, including: NGS library QC, multiplex PCR, CRISPR workflows, SNP, RFLP, MDx, total RNA QC, low-concentration RNA, and protein profiling/antibody analysis.

            You can select:

            1. System configuration based on throughput needs

            2. Cartridge types for specific applications

            3. On-site FAS support and workflow consulting to align the system with your lab protocols

            Typical run times are 2–7 minutes per sample depending on cartridge type and application. cfDNA / ctDNA runs can be as fast as 2–3 minutes per sample.

            While we do not provide Demos, we ensure your lab heads are fully trained and supported, with ongoing Decode assistance for the first 3–6 months. Plus, our money-back guarantee means if you’re not satisfied, we’ll refund the instrument’s value.


            Decode Science team
            is well equipped to help you out.




              Simoa Dry Blood Extraction Kit

              Huber, H., Montoliu-Gaya, L., Brum, W.S. et al. A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology. Nat Med (2026). https://doi.org/10.1038/s41591-025-04080-0

              Simoa Dry Blood Extraction Kit

              The Simoa Dry Blood Extraction Kit is a validated, device-agnostic solution for extracting analytes from dried plasma and dried blood spot (DPS/DBS) samples for use with Simoa® assays. It enables consistent, reproducible recovery of low-abundance biomarkers while maintaining the femtogram-level sensitivity required for clinical and translational research.

              Designed to support decentralized and remote sample collection, the kit simplifies pre-analytical workflows without compromising data quality. It is well suited for longitudinal studies, multi-site trials, and settings where traditional venous sampling and cold-chain logistics are impractical.

              Key Features of the Simoa Dry Blood Extraction Kit

              Device-agnostic compatibility

              Validated across multiple dried plasma and dried blood spot collection devices, enabling consistent analyte recovery independent of collection format. This supports reliable data generation across decentralized, remote, and longitudinal study designs.

              Standardized, semi-automated workflow

              A harmonized extraction protocol controls critical pre-analytical variables, including elution conditions, centrifugation parameters, and buffer composition. This reduces operator- and site-dependent variability and improves reproducibility across batches and study sites.

              Preservation of analytical sensitivity

              The extraction process is optimized to maintain the ultra-high sensitivity of Simoa® assays, enabling reliable detection of low-abundance biomarkers such as p-Tau 217. Suitable for neurological, inflammatory, and systemic biomarker applications where signal integrity is critical.

              Direct compatibility with Simoa® assays

              Designed specifically for downstream use with Simoa® kits, the workflow integrates into existing laboratory processes without the need for additional assay optimization or protocol development.

              Clinical Evidence: DROP-AD Study (Nature Medicine)

              Hanna Huber
              Nutrition Scientist // Ph.D // Postdoctoral researcher @DZNE Bonn & University of Gothenburg

              The Simoa Dry Blood Extraction Kit workflow is supported by evidence from the DROP-AD study, published in Nature Medicine, demonstrating that capillary dried blood samples can be used to reliably quantify key Alzheimer’s disease biomarkers.

              The multi-centre European study showed strong concordance between capillary dried blood and conventional venous plasma measurements for:

              1. p-Tau217 – strong correlation across multiple sites

              2. GFAP and NfL – reliable quantification with high plasma concordance

              The approach demonstrated good diagnostic accuracy for identifying CSF-confirmed Alzheimer’s pathology and high reproducibility with self-collected samples, supporting decentralized and remote study designs.

              Importantly, the study confirms the feasibility of this approach in high-risk and underrepresented populations, including individuals with Down syndrome, and eliminates the need for venipuncture, centrifugation, and cold-chain logistics.

              This workflow is intended for research use only and is not designed for clinical diagnosis or clinical decision-making.

              Instant Download Simoa Dry Blood Extraction Kit Tech Note

              Unlock with quick sign up!


                Designed for Real-World Clinical and Research Workflows

                The Simoa Dry Blood Extraction Kit is designed to support high-sensitivity biomarker analysis in settings where traditional venous sampling and cold-chain logistics are limiting.

                For academic and translational neuroscience teams conducting large cohort or longitudinal studies, the kit provides a standardized method for extracting biomarkers from small-volume, remotely collected samples, reducing pre-analytical variability and improving inter-site comparability.

                In pharmaceutical and biotechnology research, the workflow supports early-phase and decentralized study designs where sample volume is limited but analytical sensitivity is critical.

                For public health and global research settings, the kit enables reliable laboratory-grade biomarker analysis from capillary dried blood samples, supporting studies in low-resource or geographically distributed populations.

                Applications and Intended Use

                The Simoa Dry Blood Extraction Kit is intended for the extraction of analytes from capillary-derived dried blood and plasma collection devices to support detection of low-abundance biomarkers using Simoa® assay kits.

                For research use only.

                Kit Contents

                Each kit includes Quanterix extraction buffer and two precipitation plates.

                Julia Young

                Quanterix Business Manager

                As the official distributor of Quanterix in Australia and New Zealand, Decode Science is providing local access to Simoa® platforms, assays, and workflow solutions with region-based technical and application support.

                Quanterix Portfolio

                Proteomics in Transition: From Discovery to Diagnostic Relevance Whitepaper

                Proteomics in Transition: From Discovery to Diagnostic Relevance Whitepaper

                For years, discovery proteomics uncovered hundreds of candidate biomarkers — but most stalled before reaching the clinic. New digital platforms change that: they deliver femtogram-level sensitivity, reproducible quantification across sites, and the analytical rigor required for regulatory and clinical use.

                Why this matters
                Proteins reflect real-time biology. That means faster detection, better trial enrollment, and clearer measures of therapeutic effect. Whether you’re developing a diagnostic, designing an adaptive trial, or building a multi-omics model, the right proteomic data reduces guesswork and accelerates decisions.

                Quanterix Proteomics in Transition

                Unlock with quick sign up!


                  Dr. Ebru Boslem

                  ANZ Market Manager - Research Genomics

                  As the official distributor in Australia and New Zealand, Decode Science makes accessing genomics solutions straightforward. Our role is to connect your lab with advanced technologies, ensuring you get the right solution for your sequencing projects—delivered locally with support when you need it.

                  BCR Sequencing of 1 Million Healthy and Diseased Samples in a Single Experiment

                  BCR Sequencing of 1 Million Healthy and Diseased Samples in a Single Experiment

                  Unlock with quick sign up!


                    Key Takeaways

                    1. Profiled 1 million human B cells in a single experiment

                    2. Detected 900,000+ unique paired clonotypes across Type 1 Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, Crohn’s, Celiac, and healthy donors

                    3. Achieved sensitive detection of CDR3 regions, clonotypes, and full-length sequences at scale

                    Evercode BCR uncovered over 900,000 unique paired clonotypes across 24 samples in a single experiment. Negatively selected B cells from 12 healthy donors were purchased, while pan B cells were isolated from 12 autoimmune-diseased human PBMCs and fixed using the Evercode Cell Fixation Kit v3 to preserve cell structure and protect RNA integrity. Fixed samples were stored at -80°C until all were ready for combined processing with the Evercode BCR Mega Kit. Whole transcriptome and BCR-specific libraries were sequenced on the Illumina Novaseq X, and data were analyzed using Parse Biosciences’ Analysis Pipeline v1.3.0. Clustering with Seurat 5.0 showed that the majority of cells corresponded to major B cell subtypes, as illustrated in the UMAP below (Figure 1).

                    The assay demonstrated high sensitivity, detecting paired heavy and light chains in up to 89% of cells (Figure 2).

                    Downloads

                    Dr. Ebru Boslem

                    ANZ Market Manager - Research Genomics

                    As the official distributor in Australia and New Zealand, Decode Science makes accessing genomics solutions straightforward. Our role is to connect your lab with advanced technologies, ensuring you get the right solution for your sequencing projects—delivered locally with support when you need it.